Statistics
Publications
57
Citations
6.1K
H-Index
29
Active since
1965
Gerald B. Grindey is an author at Eli Lilly (United States) specializing in pharmacology, medicine, and cancer pharmacology.
Publications per year
1965–2015
57
57
Action of 2',2'-difluorodeoxycytidine on DNA synthesis.
Peng Huang, Sherri Chubb, Larry W. Hertel et al. · PubMed · 1991 · 884 citations
Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase.
Garth Powis, Rosanne Bonjouklian, Margareta Berggren et al. · PubMed · 1994 · 691 citations
Evaluation of the antitumor activity of gemcitabine (2',2'-difluoro-2'-deoxycytidine).
Larry W. Hertel, G B Boder, Julian S. Kroin et al. · PubMed · 1990 · 683 citations
Medicine, Oncology, Pharmacology +11
1–5 of 57